MEMO1
gene geneOn this page
Also known as CGI-27MEMO
Summary
MEMO1 (mediator of cell motility 1, HGNC:14014) is a protein-coding gene on chromosome 2p22.3, encoding Protein MEMO1 (Q9Y316). May control cell migration by relaying extracellular chemotactic signals to the microtubule cytoskeleton. It is a selective cancer dependency (DepMap: 28.6% of cell lines).
Involved in regulation of microtubule-based process. Located in cytosol and nucleus.
Source: NCBI Gene 51072 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 35 total
- Cancer dependency (DepMap): dependent in 28.6% of screened cell lines
- MANE Select transcript:
NM_001301833
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14014 |
| Approved symbol | MEMO1 |
| Name | mediator of cell motility 1 |
| Location | 2p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-27, MEMO |
| Ensembl gene | ENSG00000162959 |
| Ensembl biotype | protein_coding |
| OMIM | 611786 |
| Entrez | 51072 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 17 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000295065, ENST00000379383, ENST00000404530, ENST00000407893, ENST00000413686, ENST00000422936, ENST00000426310, ENST00000437854, ENST00000490459, ENST00000908848, ENST00000908849, ENST00000908850, ENST00000908851, ENST00000908852, ENST00000908853, ENST00000924200, ENST00000924201, ENST00000924202, ENST00000924203, ENST00000951230
RefSeq mRNA: 13 — MANE Select: NM_001301833
NM_001137602, NM_001301833, NM_001301852, NM_001371912, NM_001371913, NM_001371914, NM_001371916, NM_001371917, NM_001371918, NM_001371920, NM_001371921, NM_001385196, NM_015955
CCDS: CCDS1776, CCDS46255
Canonical transcript exons
ENST00000404530 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001552021 | 32010942 | 32011008 |
| ENSE00001557439 | 31867823 | 31868492 |
| ENSE00003502784 | 31869848 | 31869952 |
| ENSE00003512411 | 31883386 | 31883462 |
| ENSE00003695685 | 31920798 | 31920910 |
| ENSE00003699602 | 31891992 | 31892134 |
| ENSE00003699776 | 31917926 | 31918037 |
| ENSE00003700565 | 31943302 | 31943383 |
| ENSE00003701172 | 31932067 | 31932135 |
| ENSE00003797752 | 32010187 | 32010264 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 96.70.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.9090 / max 50.4187, expressed in 1726 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 27700 | 2.4004 | 1239 |
| 27699 | 1.9792 | 1168 |
| 27701 | 1.0463 | 659 |
| 27698 | 0.3487 | 161 |
| 202149 | 0.1344 | 23 |
Top tissues by expression
143 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 96.70 | gold quality |
| right testis | UBERON:0004534 | 96.49 | gold quality |
| testis | UBERON:0000473 | 95.75 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.46 | gold quality |
| muscle of leg | UBERON:0001383 | 95.18 | gold quality |
| monocyte | CL:0000576 | 94.92 | gold quality |
| leukocyte | CL:0000738 | 94.71 | gold quality |
| corpus callosum | UBERON:0002336 | 93.84 | gold quality |
| cortical plate | UBERON:0005343 | 93.67 | gold quality |
| ventricular zone | UBERON:0003053 | 93.41 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.16 | gold quality |
| lymph node | UBERON:0000029 | 92.80 | gold quality |
| esophagus mucosa | UBERON:0002469 | 92.79 | gold quality |
| heart left ventricle | UBERON:0002084 | 92.41 | gold quality |
| granulocyte | CL:0000094 | 92.38 | gold quality |
| embryo | UBERON:0000922 | 92.25 | gold quality |
| ganglionic eminence | UBERON:0004023 | 92.25 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 91.87 | gold quality |
| right adrenal gland | UBERON:0001233 | 91.69 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 91.62 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.58 | gold quality |
| heart | UBERON:0000948 | 91.52 | gold quality |
| left adrenal gland | UBERON:0001234 | 91.46 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.40 | gold quality |
| vermiform appendix | UBERON:0001154 | 91.33 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 91.25 | gold quality |
| esophagus | UBERON:0001043 | 91.17 | gold quality |
| apex of heart | UBERON:0002098 | 91.02 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 90.89 | gold quality |
| spinal cord | UBERON:0002240 | 90.79 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10283 | yes | 168.30 |
| E-ANND-3 | yes | 5.93 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F1, ESR1
miRNA regulators (miRDB)
79 targeting MEMO1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 28.6% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 15)
- data suggest that Memo controls cell migration by relaying extracellular chemotactic signals to the microtubule cytoskeleton [Memo] (PMID:15156151)
- 2.1A crystal structure and homology to class III nonheme iron-dependent dioxygenases (PMID:18045866)
- Memo-RhoA-mDia1 signaling coordinates the organization of the lamellipodial actin network, adhesion site formation, and microtubule outgrowth within the cell leading edge to sustain cell motility. (PMID:18955552)
- Memo was detected in complexes with cofilin, ErbB2 and PLCgamma1. (PMID:19223396)
- MEMO1 is involved in breast carcinogenesis via regulating insulin-like growth factor-I receptor-dependent signaling events. (PMID:22824790)
- Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2. (PMID:23861392)
- Biochemical assays revealed that Memo is a copper-dependent redox enzyme that promoted a more oxidized intracellular milieu and stimulated the production of reactive oxygen species (ROS) in cellular structures involved in migration. (PMID:24917593)
- Study identify Memo as an important key mediator between the heregulin and estrogen signaling pathways, which affects both breast cancer cell migration and proliferation. (PMID:27472465)
- HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer (PMID:27941874)
- Memo1 is a mediator of radial glial cell scaffold tiling, necessary to generate and organize neurons into functional ensembles in the developing cerebral cortex. (PMID:31277925)
- Finding MEMO-Emerging Evidence for MEMO1’s Function in Development and Disease. (PMID:33172038)
- miR-219a-1 inhibits colon cancer cells proliferation and invasion by targeting MEMO1. (PMID:33218285)
- Memo1 binds reduced copper ions, interacts with copper chaperone Atox1, and protects against copper-mediated redox activity in vitro. (PMID:36067318)
- WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity. (PMID:36627049)
- MEMO1 binds iron and modulates iron homeostasis in cancer cells. (PMID:38640016)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | memo1 | ENSDARG00000010823 |
| mus_musculus | Memo1 | ENSMUSG00000058704 |
| rattus_norvegicus | Memo1 | ENSRNOG00000006340 |
| drosophila_melanogaster | CG8031 | FBGN0038110 |
| caenorhabditis_elegans | WBGENE00016500 |
Protein
Protein identifiers
Protein MEMO1 — Q9Y316 (reviewed: Q9Y316)
Alternative names: C21orf19-like protein, Hepatitis C virus NS5A-transactivated protein 7, Mediator of ErbB2-driven cell motility 1
All UniProt accessions (3): B5MCI6, C9JSD7, Q9Y316
UniProt curated annotations — full annotation on UniProt →
Function. May control cell migration by relaying extracellular chemotactic signals to the microtubule cytoskeleton. Mediator of ERBB2 signaling. The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity. In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization. Is required for breast carcinoma cell migration.
Subunit / interactions. Interacts with ERBB2 phosphorylated on ‘Tyr-1248’.
Similarity. Belongs to the MEMO1 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y316-1 | 1 | yes |
| Q9Y316-2 | 2 | |
| Q9Y316-3 | 3 |
RefSeq proteins (13): NP_001131074, NP_001288762, NP_001288781, NP_001358841, NP_001358842, NP_001358843, NP_001358845, NP_001358846, NP_001358847, NP_001358849, NP_001358850, NP_001372125, NP_057039 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002737 | MEMO1_fam | Family |
Pfam: PF01875
UniProt features (39 total): helix 13, strand 12, mutagenesis site 6, sequence conflict 2, turn 2, splice variant 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7M8H | X-RAY DIFFRACTION | 1.75 |
| 3BCZ | X-RAY DIFFRACTION | 2.1 |
| 7KQ8 | X-RAY DIFFRACTION | 2.15 |
| 7L5C | X-RAY DIFFRACTION | 2.55 |
| 3BD0 | X-RAY DIFFRACTION | 3.01 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y316-F1 | 97.60 | 0.98 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 210
Mutagenesis-validated functional residues (6):
| Position | Phenotype |
|---|---|
| 16 | abolishes interaction with erbb2. |
| 49 | abolishes interaction with erbb2. |
| 54 | diminishes interaction with erbb2. |
| 81 | abolishes interaction with erbb2. |
| 192 | abolishes interaction with erbb2. |
| 244 | abolishes interaction with erbb2. |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-6785631 | ERBB2 Regulates Cell Motility |
| R-HSA-1227986 | Signaling by ERBB2 |
| R-HSA-162582 | Signal Transduction |
| R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
MSigDB gene sets: 181 (showing top):
AHRARNT_01, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, SP3_Q3, ONKEN_UVEAL_MELANOMA_UP, TGACATY_UNKNOWN, GGCAGTG_MIR3243P, DODD_NASOPHARYNGEAL_CARCINOMA_UP, VANTVEER_BREAST_CANCER_ESR1_DN, LIU_VMYB_TARGETS_UP, TTTGCAC_MIR19A_MIR19B, BLALOCK_ALZHEIMERS_DISEASE_DN, YKACATTT_UNKNOWN, P53_02, GCM_MAX, TTTGCAG_MIR518A2
GO Biological Process (1): regulation of microtubule-based process (GO:0032886)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): nucleus (GO:0005634), cytosol (GO:0005829), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Signaling by ERBB2 | 1 |
| Signaling by Receptor Tyrosine Kinases | 1 |
| Signal Transduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| microtubule-based process | 1 |
| regulation of cellular process | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
1078 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MEMO1 | CAMSAP2 | Q08AD1 | 520 |
| MEMO1 | CAMSAP3 | Q9P1Y5 | 490 |
| MEMO1 | ERBB2 | P04626 | 473 |
| MEMO1 | SHC1 | P29353 | 455 |
| MEMO1 | MACO1 | Q8N5G2 | 446 |
| MEMO1 | YPEL5 | P62699 | 388 |
| MEMO1 | PRDM16 | Q9HAZ2 | 374 |
| MEMO1 | SLC30A6 | Q6NXT4 | 360 |
| MEMO1 | MCC | P23508 | 346 |
| MEMO1 | DPY30 | Q9C005 | 342 |
| MEMO1 | INKA1 | Q96EL1 | 341 |
| MEMO1 | ARHGAP11A | Q6P4F7 | 337 |
| MEMO1 | TPD52L3 | Q96J77 | 334 |
| MEMO1 | NWD2 | Q9ULI1 | 333 |
| MEMO1 | AKNA | Q7Z591 | 326 |
IntAct
85 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COPRS | PRMT5 | psi-mi:“MI:0914”(association) | 0.770 |
| LNX1 | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TACC1 | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| MEMO1 | TACC1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| MEMO1 | TRIM27 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEMO1 | TCF4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEMO1 | REL | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIP6 | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM45 | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEMO1 | LZTS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM27 | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCF4 | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REL | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEMO1 | RBM45 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LZTS2 | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEMO1 | CT55 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RFX6 | MEMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (80): MEMO1 (Two-hybrid), MEMO1 (Two-hybrid), MEMO1 (Two-hybrid), MEMO1 (Two-hybrid), MEMO1 (Two-hybrid), LZTS2 (Two-hybrid), LNX1 (Two-hybrid), RBM45 (Two-hybrid), UBE3D (Affinity Capture-MS), UPF1 (Affinity Capture-MS), ANKFY1 (Affinity Capture-MS), DICER1 (Affinity Capture-MS), DNAAF2 (Affinity Capture-MS), HMBOX1 (Affinity Capture-MS), WDR54 (Affinity Capture-MS)
ESM2 similar proteins: A3MS51, A4FWD2, A4FWR5, A4YIM6, A5IKY3, A5UN65, A6LX30, A6UQ31, A6VGK5, A6VGX3, A8AB69, A8M9U2, A9A2Y3, A9A9S6, A9AA46, B1LA64, B7IGB4, B8D6F2, C3MJQ3, C3MZ11, C3N060, C3N8S4, C3NMP4, C4KJ99, D9TQ02, O26151, O27974, O67039, P61400, P61652, P95994, Q0TQH4, Q12TI1, Q18BQ3, Q46CL1, Q4JCG3, Q4R6D9, Q57846, Q803S3, Q891E7
Diamond homologs: A9A2Y3, P47085, Q10212, Q22915, Q2HJH7, Q4QQR9, Q4R6D9, Q54NZ1, Q6DJ03, Q6GNT9, Q803S3, Q91VH6, Q9HLJ1, Q9Y316, A1RTJ4, A3MS51, A4FWD2, A4WH12, A4YIM6, A5IKY3, A5UN65, A6UQ31, A6VGX3, A8AB69, A8M9U2, A9A9S6, B1LA64, B6YST0, B8D6F2, B9K748, C3MJQ3, C3MZ11, C3N060, C3N8S4, C3NMP4, C4KJ99, C5A7L6, O26151, O27974, O59292
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2473 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:31869839:GATAC:G | donor_loss | 1.0000 |
| 2:31869840:ATACT:A | donor_loss | 1.0000 |
| 2:31869841:TACT:T | donor_loss | 1.0000 |
| 2:31869842:AC:A | donor_loss | 1.0000 |
| 2:31869843:CTC:C | donor_loss | 1.0000 |
| 2:31869844:T:TA | donor_loss | 1.0000 |
| 2:31869845:CACAT:C | donor_loss | 1.0000 |
| 2:31869846:A:AC | donor_gain | 1.0000 |
| 2:31869847:C:CC | donor_gain | 1.0000 |
| 2:31883477:CATG:C | acceptor_gain | 1.0000 |
| 2:31891985:AACTT:A | donor_loss | 1.0000 |
| 2:31891986:ACTT:A | donor_loss | 1.0000 |
| 2:31891987:CTTAC:C | donor_loss | 1.0000 |
| 2:31891988:TTAC:T | donor_loss | 1.0000 |
| 2:31891989:TA:T | donor_loss | 1.0000 |
| 2:31891990:A:AC | donor_gain | 1.0000 |
| 2:31891990:A:C | donor_loss | 1.0000 |
| 2:31891990:AC:A | donor_gain | 1.0000 |
| 2:31891990:ACC:A | donor_gain | 1.0000 |
| 2:31891991:C:CA | donor_loss | 1.0000 |
| 2:31891991:C:CC | donor_gain | 1.0000 |
| 2:31891991:CC:C | donor_gain | 1.0000 |
| 2:31891991:CCC:C | donor_gain | 1.0000 |
| 2:31892050:A:AC | donor_gain | 1.0000 |
| 2:31892051:C:CC | donor_gain | 1.0000 |
| 2:31892130:TATGG:T | acceptor_gain | 1.0000 |
| 2:31892132:TGG:T | acceptor_gain | 1.0000 |
| 2:31892133:GG:G | acceptor_gain | 1.0000 |
| 2:31892135:C:CC | acceptor_gain | 1.0000 |
| 2:31892136:T:C | acceptor_gain | 1.0000 |
AlphaMissense
1963 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:31869876:C:A | G245V | 1.000 |
| 2:31869876:C:T | G245E | 1.000 |
| 2:31869879:C:T | C244Y | 1.000 |
| 2:31869882:A:T | I243K | 1.000 |
| 2:31883393:T:A | D217V | 1.000 |
| 2:31883394:C:G | D217H | 1.000 |
| 2:31883452:G:C | F197L | 1.000 |
| 2:31883452:G:T | F197L | 1.000 |
| 2:31883454:A:G | F197L | 1.000 |
| 2:31891996:A:C | H192Q | 1.000 |
| 2:31891996:A:T | H192Q | 1.000 |
| 2:31891998:G:C | H192D | 1.000 |
| 2:31891999:G:C | C191W | 1.000 |
| 2:31892000:C:T | C191Y | 1.000 |
| 2:31892005:A:C | D189E | 1.000 |
| 2:31892005:A:T | D189E | 1.000 |
| 2:31892006:T:A | D189V | 1.000 |
| 2:31892006:T:C | D189G | 1.000 |
| 2:31892009:G:A | S188F | 1.000 |
| 2:31917970:G:C | H131Q | 1.000 |
| 2:31917970:G:T | H131Q | 1.000 |
| 2:31920880:A:C | H81Q | 1.000 |
| 2:31920880:A:T | H81Q | 1.000 |
| 2:31920882:G:C | H81D | 1.000 |
| 2:32010200:C:A | W16C | 1.000 |
| 2:32010200:C:G | W16C | 1.000 |
| 2:32010202:A:G | W16R | 1.000 |
| 2:32010202:A:T | W16R | 1.000 |
| 2:31868380:C:T | G292E | 0.999 |
| 2:31868390:A:G | Y289H | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000001764 (2:31914666 A>G), RS1000029831 (2:31984441 C>T), RS1000057671 (2:31921174 A>G), RS1000081051 (2:31960874 C>A), RS1000088226 (2:31929843 C>A), RS1000098827 (2:31906173 T>C), RS1000112793 (2:31998497 C>T), RS1000120492 (2:31946477 T>C), RS1000121451 (2:31996580 T>C), RS1000127639 (2:32001788 G>A), RS1000159778 (2:31969014 A>G), RS1000169929 (2:31875142 A>G), RS1000178836 (2:32006627 G>A), RS1000192584 (2:31929307 T>C), RS1000209855 (2:31966345 T>C)
Disease associations
OMIM: gene MIM:611786 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006661_237 | Male-pattern baldness | 7.000000e-26 |
| GCST011011_61 | Youthful appearance (self-reported) | 3.000000e-08 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, affects expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alopecia